Loading...

MERCK Kommanditgesellschaft auf Aktien

MKKGYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$26.01
$0.36(1.40%)
U.S. Market opens in 7h 38m

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap56.5B
P/E Ratio18.55
EPS (TTM)$1.40
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$25.93
3 Months$32.20
1 Year Target$25.08

MKKGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKKGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.55 and a market capitalization of 56.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.01%
5-Day Change
1.33%
1-Month Change
2.45%
3-Month Change
-9.97%
6-Month Change
2.008%
Year-to-Date (YTD) Change
-9.66%
1-Year Change
-8.80%
3-Year Change
-29.03%
5-Year Change
-24.31%
All-Time (Max) Change
114.84%

Contact Information

49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateNov 16, 2007
CountryDE
Actively Trading

Frequently Asked Questions